Trial to Compare the SherpaPak™ Device vs Cold Storage

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 11, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2024

Conditions
Organ Transplant
Interventions
DEVICE

SherpaPak™ Device

The SherpaPak™ Cardiac Transport System has been developed to provide a safe, consistent method for cold ischemic storage of donor hearts for transplantation. This device is FDA approved.

OTHER

Cold Storage

FDA-approved method for organ procurement

Trial Locations (1)

90048

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER